Characteristic of TIGIT and DNAM-1 Expression on Foxp3+ γδ T Cells in AML Patients

Figure 2

Expression of DNAM-1 on Foxp3+ γδ T cells and correlation between TIGIT and DNAM-1 on Foxp3+ γδ T cells. (a) The expression of DNAM-1 on Foxp3+ γδ T cells from a HI, a de novo AML patient, an AML-NR patient, and an AML-CR patient. (b) Comparison of DNAM-1 on Foxp3+ γδ T cells from AML patients and HIs. (c) Correlation between the frequency of TIGIT+Foxp3+ and Foxp3+ γδ T cells in de novo AML patients compared with HIs. (d) Correlation between the frequency of DNAM-1+Foxp3+ and Foxp3+ γδ T cells in de novo AML patients compared with HIs. (e) Comparison of the ratio of TIGIT to DNAM-1 (TIGIT/DNAM-1) expression in Foxp3+ γδ T cells from de novo AML patients and HIs.

(a)

(b)

(c)

(d)

(e)